Clindaseptin 300 mg Kapsel, hård שוודיה - שוודית - Läkemedelsverket (Medical Products Agency)

clindaseptin 300 mg kapsel, hård

chanelle pharmaceuticals manufacturing ltd - klindamycinhydroklorid - kapsel, hård - 300 mg - laktosmonohydrat hjälpämne; klindamycinhydroklorid 326 mg aktiv substans - klindamycin - hund

Clindaseptin 75 mg Kapsel, hård שוודיה - שוודית - Läkemedelsverket (Medical Products Agency)

clindaseptin 75 mg kapsel, hård

chanelle pharmaceuticals manufacturing ltd - klindamycinhydroklorid - kapsel, hård - 75 mg - azorubin hjälpämne; klindamycinhydroklorid 81,4 mg aktiv substans; laktosmonohydrat hjälpämne - klindamycin - hund

Enrylaze האיחוד האירופי - שוודית - EMA (European Medicines Agency)

enrylaze

jazz pharmaceuticals ireland limited - crisantaspase - prekursorcell lymfoblastisk leukemi-lymfom - antineoplastiska medel - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.